The drug development sector in the United States is experiencing a significant surge in demand for Tirzepatide APIs. This effective medication, used to treat insulin resistance, has gained considerable attention from both consumers and medical practitioners. As a result, numerous manufacturers have emerged as producers of Tirzepatide APIs in the US